Calcium channel blocking and vasodilating actions of the novel dihydropyridine derivative AE0047

Clinical and Experimental Pharmacology and Physiology

Volumn 25, Issue 5, 1998, Pages 347-354

  Nishikawa, Masakuni ^a   Gohda, Maki ^a   Shinyama, Hiroshi ^a   Matzno, Sumio ^a   Yamanaga, Katsumi ^a   Kido, Hideaki ^a   Nakamura, Norifumi ^a  

^a Green Cross Company   (South Korea)

Author keywords

45Ca uptake; AE0047; Calcium channel blocker; Calcium current; Drug tissue content; Vasodilation

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; ISRADIPINE; NICARDIPINE; NITRENDIPINE; TRITIUM; WATANIDIPINE;

ANIMAL CELL; ANIMAL TISSUE; AORTA; ARTICLE; CALCIUM CURRENT; CATTLE; CELL MEMBRANE; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; GUINEA-BISSAU; HEART MUSCLE CELL; HEART VENTRICLE; IN VITRO STUDY; ISOTOPE LABELING; NONHUMAN; RAT; VASODILATATION;

EID: 0031920893     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1998.tb02362.x     Document Type: Article

References (22)

1. Godfraind T, Miller R, Wibo M. Calcium antagonism and calcium entry blockade. Pharmacol. Rev. 1986; 38: 321-416.
2. Godfraind T. Calcium antagonists and vasodilatation. Pharmacol. Ther. 1994; 64: 37-75.
3. Ohtaki Y, Uchida T, Kido H, Watanabe M. Antihypertensive effect of the novel Ca entry blocker AE0047. Jpn. J. Pharmacol. 1989; 49 (Suppl.): 210P.
4. Takeda T, Iimura O, Abe K et al. Clinical evaluation of GJ-0956 on essential hypertension: A double-blind comparative study with nitrendipine. J. Clin. Ther. Med. 1997; 13: 2907-50.
5. Nishikawa M, Okamura T, Toda N. Effect of the novel calcium antagonist AE0047 on responses of isolated dog blood vessels to vasoconstricting agents and to nerve stimulation. Folia Pharmacol. Jpn. 1995; 106: 19-29.
6. 2+ entry blocker, inhibits the responses to adrenergic nerve stimulation and substance P in dog mesenteric arteries. Eur. J. Pharmacol. 1992; 220: 27-33.
7. Koumi S, Sato R, Hisatome I, Hayakawa H, Okumura H, Katori R. Disopyramide block of cardiac sodium current after removal of the fast inactivation process in guinea pig ventricular myocytes. J. Pharmacol. Exp. Ther. 1992; 261: 1167-74.
8. Klöckner U, Isenberg G. The dihydropyridine niguldipine modulates calcium currents in vascular smooth muscle cells. Br. J. Pharmacol. 1989; 97: 957-67.
9. Godfraind T. Actions of nifedipine on calcium fluxes and contraction in isolated rat arteries. J. Pharmacol. Exp. Ther. 1983; 224: 443-50.
10. 45Ca movements and contractile responses of rat aorta and its relevance to the action of Syntocinon. J. Pharm. Pharmacol. 1984; 36: 521-6.
11. Okamiya Y, Kishimoto T, Aoki K, Tanabe H, Takeshita T. Relationship between tissue content of TC-81 and relaxation of rat aorta. Eur. J. Pharmacol. 1992; 222: 99-105.
12. 3H]-isradipine (PN 200-110) on smooth muscle cell membranes from different bovine arteries. J. Cardiovasc. Pharmacol. 1988; 11: 402-6.
13. Wibo M, DeRoth L, Godfraind T. Pharmacologic relevance of dihydropyridine binding sites in membranes from rat aorta: Kinetic and equilibrium studies. Circ. Res. 1988; 62: 91-6.
14. Burges RA, Dodd MG, Gardiner DG. Pharmacologic profile of amlodipine. Am. J. Cardiol. 1989; 64: I-10-20.
15. Gotoh Y, Kumadani S, Kawai T, Imaizumi Y, Watanabe M. Slow onset of and recovery from Ca blocking action of benidipine in rat aorta and portal vein. Jpn. J. Pharmacol. 1989; 51: 37-45.
16. Masuda Y, Iwata T, Yamashita T et al. Vasorelaxing and receptor binding properties of NZ-105, a novel dihydropyridine derivative, in isolated rabbit aorta. Arch. Int. Pharmacodyn. 1991; 312: 86-103.
17. Micheli D, Ratti E, Toson G, Gaviraghi G. Pharmacology of lacidipine, a vascular-selective calcium antagonist. J. Cardiovasc. Pharmacol. 1991; 17 (Suppl. 4): S1-8.
18. Yamanaga K, Okita M, Shinyama H et al. L-Type calcium channel blocking action of AE0047. Jpn. J. Pharmacol. 1994; 64 (Suppl.): 245P.
19. Morimoto S, Matsumura Y. Manidipine hydrochloride [CV-4093 (2HCl)]. Cardiovasc. Drug Rev. 1991; 9: 207-22.
20. Rhodes DG, Sarmiento JG, Herbette LG. Kinetics of binding of membrane-active drugs to receptor sites. Mol. Pharmacol. 1985; 27: 612-23.
21. Herbette LG, Chester DW, Rhodes DG. Structural analysis of drug molecules in biological membranes. Biophys. J. 1986; 49: 91-4.
22. Masumoto K, Takeyasu A, Oizumi K, Kobayashi T. Studies of novel 1,4-dihydropyridine Ca antagonist CS-905. I. Measurement of partition coefficient (log P) by high performance liquid chromatography (HPLC). Yakugaku Zasshi 1995; 115: 213-20 (in Japanese with an English abstract).